Cancer (Oncology)

Why we should take a second look at RNA therapeutics

Read more

Technology Transfer: Partnering with the US National Cancer Institute

Read more

Building biotech using an oncology network

Read more

Drug development robust, despite the pandemic

Read more

Developing radionuclide PARP inhibitors

Read more

The linker matters in antibody-drug conjugates

Read more

The hunt for the perfect tumour-associated antigen

Read more

Oncology approvals are on an upward trend

Read more

A new paradigm for cancer therapy emerges

Read more

A new concept for preventing tumour metastases

Read more